Basis of Presentation (Tables)

3 Months Ended

Mar. 21, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Segment Reporting Disclosure [Text Block]

Net revenue and operating profit of each division are as follows:

	12 Weeks Ended
Net Revenue (a)	3/21/2020		3/23/2019
FLNA	$	4,074	$	3,815
QFNA	634		594
PBNA	4,838		4,510
LatAm	1,310		1,241
Europe	1,839		1,620
AMESA	631		579
APAC	555		525
Total	$	13,881	$	12,884

(a) Our primary performance obligation is the distribution and sales of beverage, food and snack products to our customers. For the 12 weeks ended March 21, 2020 and March 23, 2019, our food and snack business represented approximately 55% of our consolidated net revenue. Internationally, LatAm’s food and snack business represented approximately 90% of the segment’s revenue, Europe’s beverage business and food and snack business represented approximately 55% and 45%, respectively, of the segment’s net revenue, AMESA’s beverage business and food and snack business represented approximately 35% and 65%, respectively, of the segment’s net revenue and APAC’s beverage business and food and snack business represented approximately 20% and 80%, respectively, of the segment’s net revenue. Beverage revenue from company-owned bottlers, which primarily includes our consolidated bottling operations in our PBNA and Europe segments, was approximately 40% of our consolidated net revenue. Generally, our finished goods beverage operations produce higher net revenue, but lower operating margins as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages.

	12 Weeks Ended
Operating Profit	3/21/2020			3/23/2019
FLNA (a)	$	1,202		$	1,159
QFNA (a)	150			138
PBNA (a)	297			389
LatAm	231			230
Europe (a)	146			115
AMESA	134			105
APAC (a)	142			106
Total division	$	2,302		$	2,242
Corporate unallocated expenses	(378		)	(234		)
Total	$	1,924		$	2,008

(a)

In the 12 weeks ended March 21, 2020, operating profit includes $143 million of certain charges taken as a result of the novel coronavirus (COVID-19) pandemic, including $68 million of incremental allowances for expected credit losses ($21 million in FLNA, $2 million in QFNA, $41 million in PBNA and $4 million in Europe), $44 million of write-downs against upfront payments to customers in PBNA, $26 million of inventory write-downs and product returns ($3 million in FLNA, $22 million in PBNA and $1 million in APAC) and $5 million of certain other charges ($3 million in FLNA, $1 million in PBNA and $1 million in APAC).